切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2008, Vol. 02 ›› Issue (06) : 670 -676. doi: 10.3877/cma.j.issn.1674-0807.2008.06.008

实验研究

环氧化酶-2、血管内皮生长因子在乳腺癌组织中表达及其对血管生成的影响
韩晖1, 林舜国1, 许春森1, 赵文新1, 陈大良1, 郑宇辉2, 杨映红2   
  1. 1.350001福州,福建医科大学附属协和医院普外科
    2.350001福州,福建医科大学附属协和医院病理科
  • 收稿日期:2008-04-21 出版日期:2008-12-01

Research of the expressions of cyclooxygenase-2 and vascular endothelial grow th factor and their effects on tumor angiogenesis in human

Hui HAN1, Shunguo LIN1, Chun-sen XU1, Wen-xin ZHAO1, Da-liang CHEN1, Yu-hui ZHENG1, Ying-hong YANG1   

  1. 1.Department of General Surgery,Union Hospital,Fujian Medical University,Fuzhou 350001,China
  • Received:2008-04-21 Published:2008-12-01
引用本文:

韩晖, 林舜国, 许春森, 赵文新, 陈大良, 郑宇辉, 杨映红. 环氧化酶-2、血管内皮生长因子在乳腺癌组织中表达及其对血管生成的影响[J/OL]. 中华乳腺病杂志(电子版), 2008, 02(06): 670-676.

Hui HAN, Shunguo LIN, Chun-sen XU, Wen-xin ZHAO, Da-liang CHEN, Yu-hui ZHENG, Ying-hong YANG. Research of the expressions of cyclooxygenase-2 and vascular endothelial grow th factor and their effects on tumor angiogenesis in human[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2008, 02(06): 670-676.

目的

研究环氧化酶-2(COX-2)、血管内皮生长因子(VEGF)在乳腺癌组织中的表达,并探讨其对血管生成的作用。

方法

应用免疫组织化学SP法检测30例乳腺癌组织标本和20例正常乳腺组织标本中COX-2、VEGF的表达,并用血管内皮细胞标记物CD34单克隆抗体标记行免疫组织化学染色,观察肿瘤微血管生成状况。

结果

COX-2在70.0%(21/30)乳腺癌组织中过表达,VEGF在56.7%(17/30)乳腺癌组织中过表达,与正常组织相比差异均有统计学意义;COX-2和VEGF表达相关;COX-2和VEGF表达均与肿瘤微血管生成相关。

结论

COX-2和VEGF过表达均与乳腺癌血管生成有关。

Objective

To study the expressions of cyclooxygenase-2(COX-2)and vascular endothelial growth factor(VEGF)and their effects on tumor angiogenesis in human breast carcinoma.

Methods

The expressions of COX-2 and VEGF were detected in 30 cases of primary breast carcinoma and 20 samples of normal breast tissue by immunohistochemical method.The tumor micrangium was also examined using CD34 staining.

Results

The expression rate of COX-2 and VEGF in breast carcinoma tissue was 70.0%(21/30)and 56.7%(17/30)respectively,with significant difference compared with the nomal breast tissue.A significant correlation was found between COX-2 and VEGF expressions.Both COX-2 and VEGF were significantly correlated with tumor angiogenesis.

Conclusion

Both COX-2 and VEGF are related to tumor angiogenesis in breast cancer.

表1 正常组织与乳腺癌组织中COX-2和VEGF的表达[例(%)]
图1 COX-2在乳腺癌组织中的阳性表达(SP染色 ×400)
图2 VEGF在乳腺癌组织中的阳性表达(SP染色 ×400)
表2 背阔肌肌皮瓣乳房重建术后心理干预治疗前后心身症状的比较
图3 CD34在乳腺癌组织中的阳性表达(SP染色 ×400)
[1]
Parkin D M,Bray F,Ferlay J,et al.Global cancer statistics,2002.CA Cancer J Clin,2005,55:74-108.
[2]
杨玲,李连弟,陈育德,等.中国乳腺癌发病死亡趋势的估计与预测.中华肿瘤杂志,2006,28:438-440.
[3]
Hasturk S,Kemp B,Kalapurakal SK,et al.Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma.Cancer,2002,94:1023-1031.
[4]
张宏伟,张林,陈景寒,等.血管内皮生长因子和细胞黏附分子1在非小细胞肺癌组织中的表达.中华外科杂志,2005,43:354-357.
[5]
Weidner N,Folkman J,Pozza F,et al.Tumor angiogenesis:a new significant and independent prognostic indicator in earlystage breast carcinoma.J Natl Cancer Inst,1992,84:1875-1887.
[6]
徐兵河,袁芃.乳腺癌的靶向治疗.乳腺病杂志,2005,3:4-6.
[7]
Spizzo C,Gastl C,Wolf D,et al.Correlation of COX-2 and Ep-CAM over expression in human invasive breast cancer and its impact on survival.Br JCancer,2003,88:574-578.
[8]
Denkert C,Winzer K J,Hauptmann S.Prognostic impact of cyclooxygenase-2 in breast cancer.Clin Breast Cancer,2004,4:428-433.
[9]
马涛,谷俊朝.血管内皮生长因子与乳腺癌的临床研究进展.国外医学·外科学分册,2005,32:66-70.
[10]
王宜轩,宋文华.血管内皮生长因子在乳腺癌中的研究进展.中华全科医学,2008,6:845-846.
[11]
孟令华,刘巍,宋丽楠,等.BCSG1、C-erbB-2、VEGF表达与乳腺癌临床病理因素相关性研究.中华乳腺病杂志(电子版),2007,4:82-89.
[12]
向阳,孙敏,王和勇.COX-2及其抑制剂在肿瘤防治中的作用.生命科学,2008,20:81-85.
[13]
Costa C,Soares R,Reis Filho JS,et al.Cyclo-oxygenase-2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer.JClin Pathol,2002,55:429-434.
[14]
Kirkpatrick K,Ogunkolade W,Elkak A,et al.The mRNA expression of cyclo-oxygenase-2(COX-2)and vascular endothelial growth factor(VEGF)in human breast cancer.Curr Med Res Opin,2002,18:237-241.
[15]
Liu X H,Kirschenbaum A,Yao S,et al.Up regulation of vascu larendothelial growth factor by cobalt chloride simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line.Clin Exp Metastasis,1999,17:687-694.
[16]
Uefui K,Ichikura T,Mochizuki H.Cyclooxygenase-2 expression is related to prostagland in biosynthesis and angiogenes is in gastric cancer.Clin Cancer Res,2000,6:135-138.
[17]
Bamba H,Ota S,Kato A,et al.Prostaglandins up regulate vascular endothelial growth factor production through distinct pathways in differentiated U937 cells.Biochem Biophys Res Commun,2000,273:485-491.
[18]
Chang S H,Liu C H,Conway R,et al.Role of prostagland in E2-dependent angiogenic switch in cyclooxygenase-2-induced breast cancer progression.Proc Natl Acad Sci USA,2004,101:591-596.
[19]
Ruegg C,Zaric J,Stupp R,et al.Non steroidal anti-inflammatory drugs and COX-2 inhibitors as anti-cancer therapeutics:hypes,hopes and reality.Ann Med,2003,35:476-487.
[20]
Ragel B T,Jensen R L,Gillespie D L,et al.Celecoxib inhibits meningioma tumor growth in a mouse xenograft model.Cancer,2007,109:588-597.
[1] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[2] 周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[3] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[4] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[5] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[6] 邱琳, 刘锦辉, 组木热提·吐尔洪, 马悦心, 冷晓玲. 超声影像组学对致密型乳腺背景中非肿块型乳腺癌的诊断价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 353-360.
[7] 程燕妮, 樊菁, 肖瑶, 舒瑞, 明昊, 党晓智, 宋宏萍. 乳腺组织定位标记夹的应用与进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 361-365.
[8] 涂盛楠, 胡芬, 张娟, 蔡海峰, 杨俊泉. 天然植物提取物在乳腺癌治疗中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 366-370.
[9] 朱文婷, 顾鹏, 孙星. 非酒精性脂肪性肝病对乳腺癌发生发展及治疗的影响[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 371-375.
[10] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[11] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[12] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[13] 王玲艳, 高春晖, 冯雪园, 崔鑫淼, 刘欢, 赵文明, 张金库. 循环肿瘤细胞在乳腺癌新辅助及术后辅助治疗中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 630-633.
[14] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
[15] 朱佳琳, 方向, 贵诗雨, 黄丹, 周小雨, 郭文恺. 大鼠切口疝腹膜前间隙补片修补术后血清中VEGF 和Ang-1 的表达情况[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 703-707.
阅读次数
全文


摘要